Acarbose Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Phase IV Study to Assess the Efficacy and Safety of Dapagliflozin Compared With Acarbose in Drug-Naive Patients With T2DM in China
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Dapagliflozin/Acarbose Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials

A Phase IV Study in Drug-Naive Patients With T2DM in China
Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: Dapagliflozin;   Drug: Acarbose Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials

A Phase IV Study to Assess the Efficacy and Safety of Dapagliflozin Compared With Acarbose in Drug-Naive Patients With T2DM in China
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Dapagliflozin/Acarbose Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials

A Phase IV Study in Drug-Naive Patients With T2DM in China
Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: Dapagliflozin;   Drug: Acarbose Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials